Safety and Efficacy of Itacitinib in Participants With Bronchiolitis Obliterans Syndrome Following Lung Transplantation
Clinical trial NCT03978637 · TERMINATED
Trial details
- NCT number
- NCT03978637
- Sponsor
- Incyte Corporation
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-04
- Primary completion
- 2023-10-13
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.